Skip to Content
Merck
  • Protocol to generate human pluripotent stem cell-derived pancreatic β cells through methionine and zinc deprivation.

Protocol to generate human pluripotent stem cell-derived pancreatic β cells through methionine and zinc deprivation.

STAR protocols (2023-03-24)
Erinn Zixuan Sim, Takayuki Enomoto, Nobuaki Shiraki, Shoen Kume
ABSTRACT

Efforts have been made to establish a differentiation protocol mimicking pancreatic development and to derive pancreatic β cells for regenerative medicine. Here, we present an optimized pancreatic β cell differentiation procedure using human pluripotent stem cells. We describe steps for a short 5-h methionine deprivation pretreatment followed by the application of zinc-deprived media at definitive endoderm differentiation stages to improve differentiation efficiency. The application of methionine and zinc deprivation facilitates the generation of functional pancreatic β cells. For complete details on the use and execution of this protocol, please refer to Sim et al. (2022).1.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-Glucagon antibody produced in mouse, clone K79bB10, ascites fluid
Sigma-Aldrich
Anti-Somatostatin antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-Sox9 Antibody, Chemicon®, from rabbit
Sigma-Aldrich
LDN193189 hydrochloride, ≥98% (HPLC)